STS injections for calcinosis in scleroderma
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism, Skin clinical trials.
This trial tests if injecting a medication called STS directly into calcium deposits can relieve pain and symptoms. It may help patients with scleroderma or related conditions who have painful calcium lumps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of systemic sclerosis, mixed connective tissue disease, or inflammatory myopathy.
- You are 18 years or older.
- You can understand and agree to the study procedures.
- You have calcium deposits shown on an X-ray or ultrasound.
- You need relief from symptoms caused by calcium deposits.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study will use CT scans to measure calcium deposits under the skin in people with scleroderma. It may help doctors better understand and track this condition.
This pilot study tests a medicine called sodium thiosulfate (given as a skin shot) to treat abnormal calcium or bone formation in places they don’t belong. It’s meant for people whose condition is causing significant problems, and who are not planning surgery for the next year.
This study tests whether blocking a protein called TL1A can help reduce skin thickening and improve the immune system in people with systemic sclerosis (a condition where skin becomes hard and thick). Researchers will compare skin and blood samples from people with systemic sclerosis to healthy volunteers.
This trial tests whether special cells from umbilical cord (UC-MSC) can help treat systemic sclerosis—a disease that causes skin and organ hardening. If you have early systemic sclerosis that hasn't improved enough with standard treatments, this study may offer a new option.
This study tests a skin patch with botulinum toxin to ease blood vessel spasms in the fingers of people with scleroderma, which can cause pain and sores. It may help improve blood flow and reduce finger discomfort.
This study tests whether an added treatment called pyrophosphate can reduce calcium deposits in the skin caused by systemic sclerosis (SSC). You may be able to join if you meet standard diagnosis criteria and don’t have certain heart- and thyroid-related issues.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.